cbdMD, Inc.
YCBD
$0.8569
-$0.0531-5.84%
AMEX
| 12/31/2024 | 09/30/2024 | 06/30/2024 | 03/31/2024 | 12/31/2023 | |
|---|---|---|---|---|---|
| Revenue | 5.11M | 4.56M | 5.17M | 4.38M | 5.38M |
| Total Other Revenue | -- | -- | -- | -- | -- |
| Total Revenue | 5.11M | 4.56M | 5.17M | 4.38M | 5.38M |
| Cost of Revenue | 1.71M | 2.10M | 1.77M | 1.80M | 1.82M |
| Gross Profit | 3.40M | 2.45M | 3.40M | 2.58M | 3.56M |
| SG&A Expenses | 2.88M | 2.89M | 3.20M | 3.38M | 3.82M |
| Depreciation & Amortization | 298.00K | 287.80K | 287.80K | 290.60K | 283.70K |
| Other Operating Expenses | 306.40K | -429.30K | 290.60K | 460.20K | 514.20K |
| Total Operating Expenses | 5.20M | 4.87M | 5.56M | 5.93M | 6.44M |
| Operating Income | -86.30K | -316.60K | -382.00K | -1.55M | -1.07M |
| Income Before Tax | 15.10K | -152.80K | 459.70K | -3.01M | -996.50K |
| Income Tax Expenses | -- | -- | -- | -- | -- |
| Earnings from Continuing Operations | 15.10K | -152.80K | 459.70K | -3.01M | -996.50K |
| Earnings from Discontinued Operations | -- | -- | -- | -- | -- |
| Extraordinary Item & Accounting Change | -- | -- | -- | -- | -- |
| Minority Interest in Earnings | -- | -- | -- | -- | -- |
| Net Income | 15.10K | -152.80K | 459.70K | -3.01M | -996.50K |
| EBIT | -86.30K | -316.60K | -382.00K | -1.55M | -1.07M |
| EBITDA | 211.70K | -28.80K | -94.30K | -1.26M | -782.10K |
| EPS Basic | -1.73 | -1.41 | -1.20 | -10.84 | -5.40 |
| Normalized Basic EPS | -0.08 | -0.24 | -0.55 | -5.09 | -1.80 |
| EPS Diluted | -1.73 | -1.42 | -1.20 | -10.84 | -5.40 |
| Normalized Diluted EPS | -0.08 | -0.24 | -0.55 | -5.09 | -1.80 |
| Average Basic Shares Outstanding | 569.00K | 820.60K | 449.10K | 370.10K | 370.10K |
| Average Diluted Shares Outstanding | 569.00K | 820.60K | 449.10K | 370.10K | 370.10K |
| Dividend Per Share | -- | -- | -- | -- | -- |
| Payout Ratio | -- | -- | -- | -- | -- |